Skip to content

Baxter International BAX Europe Middle East And Africa — Net Revenue

Discontinued — last reported Q1 '18

Similar metrics at other companies

McCormick & Company, Incorporated logo
MKCEurope Middle East And Africa — Net Revenue
$237.9M+6.2%
Zebra Technologies logo
ZBRAEMEA — Total Net sales
$507M+13.2%
Avery Dennison logo
AVYEMEA — Revenue
$498.5M+0.8%
Illumina logo
ILMNEurope Middle East And Africa — Revenue
$208M+3.0%
Natera, Inc. logo
NTRAEurope Middle East India And Africa — Revenue
$6.12M+2.5%
Arrow Electronics logo
ARWEMEA — Revenue
$3.41B+38.4%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:SalesRevenueNet.

The official record: Baxter International’s 10-Q, filed May 9, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does europe middle east and africa — net revenue mean?
The total net sales revenue earned by the company from operations in the Europe, Middle East, and Africa region.
How do you interpret europe middle east and africa — net revenue?
An increase suggests growing market share or higher demand for medical products in the EMEA region, while a decrease may indicate regional economic headwinds or increased competition.
How does europe middle east and africa — net revenue compare across companies?
Comparable to regional revenue reporting by other global medical device manufacturers, often benchmarked against regional GDP growth and healthcare expenditure trends.